Press Releases

Mentor Capital Acquires 50% of Brighter Day Health For $5M (01/17/12)

Mentor Capital Begins its 2012 Cancer Roll-up Strategy (01/10/12)

MNTR Acquires 30 Percent of European Cancer Vaccine for $4.71 Million (11/28/11)

Mentor Capital Adds to European Cancer Portfolio with AGI Biopharmaceuticals Melanoma Vaccine (10/31/2011)

Mentor Capital Reports Mid-Year Profits for 2011 (10/06/2011)

Mentor Capital Initiates Discussions for Potential Merger (08/18/2011)

Mentor Capital Seeks Funding Partners as Neutron Cancer Therapy Accelerates (07/26/2011)

Cancer Immunotherapy Index Outpaces Biotechs (07/12/11)

Increased Chinese and International Visitors to Mentor Capital Site (06/20/11)

CEO Purchases an Additional 3.14% of MNTR Shares (06/09/11)

MNTR Drafts Five Cancer Funding Contracts for $40 Million (06/08/11)

MNTR Screens Cancer Companies For Investment At ASCO (05/23/11)

MNTR Acquires $5M Hadron Neutron Therapy Interest (05/05/11)

$125 Million for Socially Responsible Direct Cancer Funding (05/03/11)

Advaxis Added To Cancer Immunotherapy Index (02/15/11)

MNTR In Discussion With Breast Cancer Immunotherapy Company (01/21/11)

Mentor Capital to Expand Funding Bridge Over Cancer Gap (12/21/10)

Nobel Laureate Reinforces the Mentor Capital Strategy to Fund (12/07/10)

Mentor Capital Cancer Immunotherapy Index Gains on Medicare Advisory Committee Approval of $93,000 Provenge Immunotherapy Treatment by Dendreon for Prostate Cancer (11/24/10)

Mentor Capital Sees a Shift to Public Acceptance of Dendreon-like (04/26/10)

Mentor Capital Cancer Immunotherapy Index Gains on Health Care Bill 12-Year Exclusive Period for Biologic Drugs (03/23/10)

Provectus Pharmaceuticals, Inc. Added to Cancer Immunotherapy Index by Mentor Capital, Inc. Experiences 23% One-Week Gain (03/01/10)

Mentor Capital Takes Investment Position in Each of 10 Cancer Immunotherapy Index Companies (01/19/10)

Mentor Capital Retains Network 1 Financial Securities for Comprehensive Investment Banking Services (01/11/10)

Mentor Capital Announces Plan for New 2010 Actively Managed Cancer Immunotherapy Index and 45 Day Call on C Warrants for CI Index Seed Funding (12/14/09)

Mentor Capital, Inc. Speaks on Cancer Investment with Long Island Investment Banking Group (09/30/09)

Quantum Immunologics Achieves Major Funding in Support of Ongoing FDA Trials (07/15/09)

Mentor Capital, Inc. Gains 135% and Calls in $3 Million Equity Tranche (09/06/08)

Mentor Capital, Inc. (MNTR) Initiates Trading at $1.05/sh (P/E of 2.7x) (09/02/08)